Net shares · 365d
-6.3K
0 buy · 6.3K sell
Net value · 365d
-$3.0M
$0 in · $3.0M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
5
0 buy · 6.3K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
VRTX Sell·S
EVP, Chief Scientific Officer · 10b5-1
$15.0K
33 sh · $453.45
Own -0%
-
VRTX Sell·S
EVP, Chief Scientific Officer · 10b5-1
$301.5K
620 sh · $486.35
Own -8%
-
VRTX Other·F
EVP, Chief Scientific Officer · 10b5-1
$282.3K
582 sh · $485.11
Own -7%
-
VRTX Sell·S
EVP, Chief Scientific Officer · 10b5-1
$1.8M
3.6K sh · $484.31 avg · 2 lots
Own -30%
-
VRTX Grant·A
EVP, Chief Scientific Officer · 10b5-1
$0
2.6K sh
Own +24%
-
VRTX Other·F
EVP, Chief Scientific Officer · 10b5-1
$537.0K
1.1K sh · $483.75
Own -8%
-
VRTX Other·F
EVP, Chief Scientific Officer
$1.1M
2.3K sh · $487.76
Own -18%
-
VRTX Sell·S
EVP, Chief Scientific Officer · 10b5-1
$930.5K
2.0K sh · $460.43
Own -14%
-
VRTX Other·F
EVP, Chief Scientific Officer · 10b5-1
$527.9K
1.1K sh · $468.41
Own -7%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | VRTX | Sell S | 33 | $15.0K |
| Feb 25, 2026 | VRTX | Sell S | 620 | $301.5K |
| Feb 24, 2026 | VRTX | Other F | 582 | $282.3K |
| Feb 18, 2026 | VRTX | Sell S | 3.6K2 lots | $1.8M |
| Feb 17, 2026 | VRTX | Grant A | 2.6K | $0 |
| Feb 17, 2026 | VRTX | Other F | 1.1K | $537.0K |
| Feb 13, 2026 | VRTX | Other F | 2.3K | $1.1M |
| Feb 11, 2026 | VRTX | Sell S | 2.0K | $930.5K |
| Feb 10, 2026 | VRTX | Other F | 1.1K | $527.9K |
Buy Sell Non-market (grant · exercise · gift)
About Bunnage Mark E.
This profile aggregates every SEC Form 4 insider transaction reported by Bunnage Mark E. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.